Table 3.
Generalised linear mixed model to analyse the influence of tumor and ablation characteristics on the primary efficacy rate.
| Predictor | Univariable analysis | Multivariable analysis | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p-value | OR | 95% CI | p-value | |
| Guidance | ||||||
| Manual | ||||||
| Stereotactic | 1.79 | 1.01, 3.18 | 0.046 | 1.95 | 1.07, 3.55 | 0.028 |
| Lesion size | ||||||
| < 3 cm | ||||||
| ≥ 3 cm | 0.44 | 0.23, 0.82 | 0.010 | 0.38 | 0.20, 0.74 | 0.004 |
| Tumor entity | ||||||
| HCC | ||||||
| CRC | 0.53 | 0.28, 1.00 | 0.048 | 0.47 | 0.24, 0.94 | 0.033 |
| CCC | 0.31 | 0.11, 0.85 | 0.023 | 0.31 | 0.11, 0.84 | 0.021 |
| Other | 1.16 | 0.40, 3.33 | 0.78 | 1.17 | 0.38, 3.59 | 0.79 |
| Segments I, VII or VIII | 1.36 | 0.77, 2.39 | 0.29 | 1.39 | 0.74, 2.61 | 0.31 |
| Subphrenic location | 1.00 | 0.59, 1.69 | > 0.99 | 0.99 | 0.57, 1.71 | 0.97 |
| Subcapsular location | 1.20 | 0.72, 2.00 | 0.49 | 1.20 | 0.70, 2.06 | 0.51 |
| Proximity to vessel | 0.74 | 0.44, 1.27 | 0.28 | 0.81 | 0.48, 1.36 | 0.43 |
Subphrenic and subcapsular location are defined as a distance less than 10 mm to the diaphragm or liver capsule.
OR odds ratio, 95% CI 95% confidence interval, HCC hepatocellular carcinoma, CRC colorectal cancer, CCC cholangiocellular carcinoma.